Wang, X.; Zhou, Y.; Wang, Y.; Wang, X.; Zhang, Y.; Mao, Y.; Zhang, L.; Qi, J.; Zhang, Y.; Lyu, F.;
et al. SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. J. Clin. Med. 2022, 11, 4765.
https://doi.org/10.3390/jcm11164765
AMA Style
Wang X, Zhou Y, Wang Y, Wang X, Zhang Y, Mao Y, Zhang L, Qi J, Zhang Y, Lyu F,
et al. SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. Journal of Clinical Medicine. 2022; 11(16):4765.
https://doi.org/10.3390/jcm11164765
Chicago/Turabian Style
Wang, Xu, Yi Zhou, Yan Wang, Xiang Wang, Yu Zhang, Yufei Mao, Long Zhang, Ji Qi, Yining Zhang, Feng Lyu,
and et al. 2022. "SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide" Journal of Clinical Medicine 11, no. 16: 4765.
https://doi.org/10.3390/jcm11164765
APA Style
Wang, X., Zhou, Y., Wang, Y., Wang, X., Zhang, Y., Mao, Y., Zhang, L., Qi, J., Zhang, Y., Lyu, F., Gu, L., Yu, R., & Zhou, X.
(2022). SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide. Journal of Clinical Medicine, 11(16), 4765.
https://doi.org/10.3390/jcm11164765
